Abstract
Lymphomatoid papulosis (LyP), a low-grade malignant T-cell lymphoma, belongs to the spectrum of cutaneous CD30+ lymphoproliferative diseases. It clinically manifests as necrotic papules or nodules, and superficial scar may be left after regression in some cases. Since lesions tend to recur and heal spontaneously, the lesions at different stages of evolution usually coexist. The histologic manifestations of LyP are various, and usually present as a spectrum. Pathologically, LyP is characterized by the presence of CD30 + neoplastic cells, and can easily be mistaken for other benign or malignant diseases. At present, no specific treatments for LyP are available, and no treatments can alter the natural history of LyP. In general, active treatments are not recommended. LyP has a good prognosis, but may be followed by other malignant lymphomas, so a long-term follow-up is warranted. Key words: Lymphomatoid papulosis; Lymphoma, T-Cell; Diagnosis; Pathology, clinical; Immunophenotyping
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: International Journal of Dermatology and Venereology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.